Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-077205
Date:2021-06-02
Issuer: NABRIVA THERAPEUTICS PLC (NBRV)
Original Submission Date:

Reporting Person:

CORRIGAN MARK
414 COMMERCE DR.
SUITE 120 FORT WASHINGTON, PA 19034

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
SHARE OPTIONS 1.39 2021-06-02 deemed execution date A 10,500 (a) 2031-06-01 ordinary shares 10,500 $1.39 10,500 direct
Footnotes
IDfootnote
f1 the option was granted on june 2, 2021.
f2 the option will vest over a three-year period on a monthly pro rata basis beginning on june 2, 2021 and subject to the reporting person's continued service on the board of directors of the issuer.
WhaleWisdom Logo

Elevate your investments